Belimumab With Rituximab for Primary Membranous Nephropathy

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

מצבים רפואיים

Membranous Nephropathy · Nephrotic Syndrome

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • University of Alabama at Birmingham School of Medicine: Division of Nephrology, Birmingham, Alabama, United States

    Contact: Study coordinator (Maria El Hachem) · mehachem@uabmc.edu · 205-975-0549
    Contact: Principal Investigator (Dana Rizk)
  • University of Arkansas, Little Rock, Arkansas, United States

    Contact: Study coordinator (Gail Runnells) · RunnellsGailAnn@uams.edu · 501-526-7956
    Contact: Principal Investigator (Srilakshmi Ravula)
  • University of California San Francisco, San Francisco, California, United States

    Contact: Study coordinator (Juan Espinoza) · Juan.Espinoza@ucsf.edu · 415-502-3618
    Contact: Principal Investigator (Raymond Hsu)
  • Stanford University School of Medicine: Division of Nephrology, Stanford, California, United States

    Contact: Study coordinator (Brittany Yeung) · yeungb@stanford.edu · (650) 498-3116
    Contact: Study coordinator (Elizabeth Chen) · echen15@stanford.edu
    Contact: Principal Investigator (Fahmeedah Kamal)
  • The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center:Division of Nephrology and Hypertension, Torrance, California, United States

    Contact: Study coordinator (Janine LaPage) · jlapage@lundquist.org · 310-222-4104
    Contact: Principal Investigator (Sharon G. Adler)
  • University of Colorado, Aurora, Colorado, United States

    Contact: Study coordinator (Lizzy Kickery) · Lizzy.kickery@cuanschutz.edu · 303-724-7790
    Contact: Principal Investigator (Amber Podoll, MD)
  • Mayo Clinic Jacksonville: Department of Nephrology and Hypertension, Jacksonville, Florida, United States

    Contact: Study coordinator (Tia Wilkes) · wilkes.quantia@mayo.edu · 904-953-3636
    Contact: Principal Investigator (Nabeel Aslam)
  • University of Miami Miller School of Medicine, Div of Nephrology, Miami, Florida, United States

    Contact: Study coordinator (Carlos D Bidot) · cbidot2@med.miami.edu · 305-243-8793
    Contact: Principal Investigator (Jair Munoz Mendoza)
  • Johns Hopkins, Baltimore, Maryland, United States

    Contact: Study coordinator (Kristin Lyman) · klyman1@jh.edu · (734) 276-1248
    Contact: Principal Investigator (Duvuru Geetha)
  • National Institutes of Health Clinical Center, Bethesda, Maryland, United States

    Contact: Study coordinator (Lilian V. Howard, CRNP) · howardlv@mail.nih.gov · 301-594-0298
    Contact: Principal Investigator (Meryl A. Waldman)
  • University of Michigan, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Jennifer DeLuca) · delucaj@med.umich.edu · 734-936-0369
    Contact: Principal Investigator (Andrea Oliverio)
  • University of Minnesota Health Clinical Research Unit, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Brady Wallner) · walln080@umn.edu · 612-626-3415
    Contact: Principal Investigator (Patrick H. Nachman)
  • Washington University in St. Louis, St Louis, Missouri, United States

    Contact: Study coordinator (Emily Green) · green.e@wustl.edu · 314-273-0339
    Contact: Principal Investigator (Tinting Li)
  • University of Nebraska, Omaha, Nebraska, United States

    Contact: Study coordinator (Tammy Jones, RN) · tamjones@unmc.edu · 402-559-4335
    Contact: Principal Investigator (Prasanth Ravipati)
  • Columbia University Medical Center: Division of Nephrology, New York, New York, United States

    Contact: Study coordinator (Anup Pradhan) · arp2209@cumc.columbia.edu · 212-305-5037
    Contact: Principal Investigator (Andrew S. Bomback)
  • University of North Carolina School of Medicine: Division of Nephrology and Hypertension, Kidney Center, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Anne Froment) · anne_froment@med.unc.edu · 919-445-2622
    Contact: Principal Investigator (Vimal K. Derebail)
  • Cleveland Clinic, Cleveland, Ohio, United States

    Contact: Study coordinator (Sandra Hodnick) · hodnics@ccf.org · 216-444-0124
    Contact: Principal Investigator (John Sedor)
  • Ohio State University Wexner Medical Center: Division of Nephrology, Columbus, Ohio, United States

    Contact: Study coordinator (Laci Roberts) · laci.roberts@osumc.edu · 614-685-5323
    Contact: Principal Investigator (Isabelle Ayoub)
  • University of Pennsylvania: Department of Medicine: Renal-Electrolyte and Hypertension Division, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Krishna Kallem, MD, MPH) · Krishna.Kallem@pennmedicine.upenn.edu · 484-358-0315
    Contact: Principal Investigator (Gaia Coppock)
  • Providence Medical Research Center, Providence Health Care: Nephrology, Spokane, Washington, United States

    Contact: Study coordinator (Nicole Maser, MSH, RN) · nicole.maser@providence.org · 509-474-5315
    Contact: Principal Investigator (Katherine R. Tuttle)
מובילי המחקר
  • Patrick Nachman

    Study Chair

    University of Minnesota, Department of Medicine, Division of Renal Diseases and Hypertension

  • Iñaki Sanz

    Study Chair

    Emory University, Department of Medicine, Division of Rheumatology